Acanthamoeba endophthalmitis during treatment for cutaneous disease in a renal transplant patient. uri icon

Overview

abstract

  • Acanthamoeba infections are difficult to diagnose and treat. We present a renal transplant patient who developed Acanthamoeba endophthalmitis on therapy with posaconazole and miltefosine for cutaneous acanthamobiasis. The patient was maintained on intracameral voriconazole injections, and oral azithromycin, fluconazole, and flucytosine. This case highlights novel presentations and treatments for acanthamoebic infection.

authors

  • Kutner, Allison
  • Aldrich, Margaret
  • Patel, Sarju
  • Kang, Joann J
  • Amin, Bijal
  • Mann, Ranon
  • Ali, Ibne Karim M
  • Martines, Roosecelis Brasil
  • Cope, Jennifer Rittenhouse
  • De Boccardo, Graciela O
  • Puius, Yoram A

publication date

  • February 12, 2018

Research

keywords

  • Amebiasis
  • Amebicides
  • Endophthalmitis
  • Kidney Transplantation
  • Skin Diseases, Parasitic

Identity

PubMed Central ID

  • PMC5973505

Scopus Document Identifier

  • 85041917464

Digital Object Identifier (DOI)

  • 10.1111/tid.12843

PubMed ID

  • 29359845

Additional Document Info

volume

  • 20

issue

  • 2